Pharmaceutical Executive-01-01-2019

Pharmaceutical Executive

8 Tipping Points: Pharm Exec’s 2019 Industry Forecast

January 23, 2019

Features

39

1

Pharm Exec’s annual look at what lies ahead for the biopharma industry in the coming months examines eight key trends that are seemingly at tipping points in their evolution and poised to shape the life sciences landscape in 2019.

Ipsen’s David Meek: Tasked to Transform

January 21, 2019

Features

39

1

In this Q&A, American-born David Meek, today CEO of Paris-based multinational Ipsen, discusses the drugmaker's bold global expansion and R&D transformation-driven by revamped leadership, a biotech mindset, and promoting external innovation.

Pharmaceutical Executive, January 2019 Issue (PDF)

January 01, 2019

Issue PDF

39

1

Click the title above to open the Pharmaceutical January 2019 issue in an interactive PDF format.

Country Report: Turkey

January 01, 2019

Special Sponsored Section

39

1

Despite market access hurdles, Turkey’s pharmaceutical market holds tremendous growth potential-in both value and volume. But will the country be able to take that final step in creating a regulatory and economic environment that is conducive to further upward development?